CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 399.83B | 391.69B | 384.33B | 376.74B | 370.66B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 399.83B | 391.69B | 384.33B | 376.74B | 370.66B |
| Cost of Revenue | 346.71B | 339.39B | 333.20B | 325.72B | 321.41B |
| Gross Profit | 53.13B | 52.30B | 51.13B | 51.02B | 49.25B |
| SG&A Expenses | 43.11B | 42.15B | 41.79B | 41.68B | 41.23B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 389.82B | 381.54B | 374.99B | 367.41B | 362.64B |
| Operating Income | 10.02B | 10.15B | 9.34B | 9.33B | 8.02B |
| Income Before Tax | 2.14B | 2.91B | 6.50B | 7.19B | 6.15B |
| Income Tax Expenses | 408.00M | 2.48B | 2.01B | 1.94B | 1.56B |
| Earnings from Continuing Operations | 1.73K | 428.00 | 4.49K | 5.24K | 4.59K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 40.00M | 41.00M | 42.00M | 36.00M | 28.00M |
| Net Income | 1.77B | 469.00M | 4.53B | 5.28B | 4.61B |
| EBIT | 10.02B | 10.15B | 9.34B | 9.33B | 8.02B |
| EBITDA | 14.63B | 14.75B | 13.97B | 13.95B | 12.62B |
| EPS Basic | 1.40 | 0.39 | 3.59 | 4.19 | 3.67 |
| Normalized Basic EPS | 4.54 | 4.71 | 4.29 | 4.26 | 3.60 |
| EPS Diluted | 1.37 | 0.38 | 3.58 | 4.19 | 3.66 |
| Normalized Diluted EPS | 4.52 | 4.70 | 4.28 | 4.25 | 3.59 |
| Average Basic Shares Outstanding | 5.07B | 5.06B | 5.05B | 5.04B | 5.03B |
| Average Diluted Shares Outstanding | 5.09B | 5.06B | 5.05B | 5.04B | 5.05B |
| Dividend Per Share | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 |
| Payout Ratio | 192.14% | 722.81% | 74.62% | 63.88% | 73.10% |